Stanford rat studies with yohimbine HCI "lead to suggestion that alpha-adrenoceptors are important modulators of sexual arousal in intact male rats," according to abstract of study in Science August 24 issue. Stanford press release says "this is the most powerful drug yet tested for stimulating sexual behavior in male rats." Human work is underway. Yohimbine is marketed as Yohimex tabs by Kramer Pharmacal. Its approved indications state: "Yohimex is indicated as a sympathicolytic and mydriactic. It may have activity as an aphrodisiac"
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”